Tern Plc publishes presentations from Device Authority and Talking Medicines investor event

Tern plc

Tern Plc (LON:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things technology businesses, has announced that following its online presentation and a Q&A session yesterday evening involving Tern’s portfolio companies Device Authority and Talking Medicines, copies of the presentations from the participating companies can be found via the links below:

Device Authority presentation:  

Talking Medicines presentation:

In addition a recording of the event will shortly be available to view on Tern plc’s website at: https://www.ternplc.com/resources

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines joins 2026 UK AI Index

Talking Medicines joins the UK AI Index 2026, confirming its growing role in data-driven healthcare strategy.

AI in Healthcare 2025

In 2025, AI began reshaping healthcare delivery and marketing with practical applications, signalling a maturing investment landscape.

Talking Medicines targets messaging risk in pharma brand strategy

Talking Medicines reduces messaging risk for pharma brands by measuring real-time HCP response.

Agentless security for untouchable IoT devices

Agentless IoT security provides identity‑driven protection for devices that cannot be directly managed, turning blind spots into governed assets.

Virtual reality surgical training wins industry attention with scalable model

A new VR training solution backed by Orbis and Fundamental XR is gaining global traction by tackling real-world gaps in surgical education.

Tern Plc publishes presentations from Device Authority and Talking Medicines investor event

Tern Plc has released copies of the presentations delivered by portfolio companies Device Authority and Talking Medicines during its recent online investor presentation and Q&A session.

Search

Search